|
76
|
275
|
4kspA |
Crystal structure of human b-raf bound to a dfg-out inhibitor tak-632 |
|
91
|
291
|
4lg4A |
Structural basis for autoactivation of human mst2 kinase and its regulation by rassf5 |
|
80
|
281
|
4knbA |
C-met in complex with osi ligand |
|
106
|
348
|
4kinA |
Crystal structure of mitogen-activated protein kinase 14 (p38-h5) complex with 5-(2-chlorophenyl)-n-(5-(cyclopropylcarbamoyl)-2-methylphenyl)-2-thiophenecarboxamide |
|
110
|
391
|
4l6qA |
Rock2 in complex with benzoxaborole |
|
81
|
272
|
4kaoA |
Focal adhesion kinase catalytic domain in complex with 1-(5-tert-butyl-2-p-tolyl-2h-pyrazol-3-yl)-3-(4-pyridin-3- yl-phenyl)-urea |
|
79
|
273
|
4k1bA |
Structure of pim-1 kinase bound to n-(5-(2-fluorophenyl)-1h-pyrrolo[2,3-b]pyridin-3-yl)-5-((((3r,4r)-3-fluoropiperidin-4-yl)methyl)amino)pyrazolo[1,5-a]pyrimidine-3-carboxamide |
|
230
|
655
|
4kikA |
Human ikb kinase beta |
|
74
|
275
|
4ksqA |
Crystal structure of human b-raf bound to a dfg-out inhibitor 5b |
|
76
|
290
|
4l67A |
Crystal structure of catalytic domain of pak4 |
|
107
|
343
|
4idtA |
Crystal structure of nik with 11-bromo-5,6,7,8-tetrahydropyrimido[4',5':3,4]cyclohepta[1,2-b]indol-2-amine (t28) |
|
85
|
293
|
4j53A |
Crystal structure of plk1 in complex with tak-960 |
|
100
|
320
|
4jnwA |
Bacterially expressed titin kinase |
|
82
|
287
|
4i20A |
Crystal structure of monomeric (v948r) primary oncogenic mutant l858r egfr kinase domain |
|
100
|
330
|
4ianA |
Crystal structure of apo human prpf4b kinase domain |
|
96
|
348
|
4j1rA |
Crystal structure of gsk3b in complex with inhibitor 15r |
|
80
|
300
|
4jg8A |
Structure of rsk2 t493m ctd mutant bound to 2-cyano-n-(1-hydroxy-2-methylpropan-2-yl)-3-(3-(3,4,5-trimethoxyphenyl)-1h-indazol-5-yl)acrylamide |
|
97
|
354
|
4hyuA |
Crystal structure of jnk1 in complex with jip1 peptide and 4-{4-[4-(3-methanesulfonyl-propoxy)-indazol-1-yl]-pyrimidin-2-ylamino}-cyclohexan |
|
90
|
302
|
4ivbA |
Jak1 kinase (jh1 domain) in complex with the inhibitor trans-4-{2-[(1r)-1-hydroxyethyl]imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6h)-yl}cyclohexanecarbonitrile |
|
82
|
266
|
4jbqA |
Novel aurora kinase inhibitors reveal mechanisms of hurp in nucleation of centrosomal and kinetochore microtubules |
|
70
|
275
|
4jvgA |
B-raf kinase in complex with birb796 |
|
81
|
265
|
4jajA |
Crystal structure of aurora kinase a in complex with benzo[c][1,8]naphthyridin-6(5h)-one |
|
78
|
274
|
4jx3A |
Crystal structure of pim1 kinase |
|
70
|
279
|
4js8A |
Crystal structure of ttk kinase domain with an inhibitor: 401348 |
|
86
|
324
|
4jq8A |
Crystal structure of egfr kinase domain in complex with compound 4b |
|
85
|
273
|
4i4eA |
Structure of focal adhesion kinase catalytic domain in complex with hinge binding pyrazolobenzothiazine compound. |
|
107
|
336
|
4iayA |
Room temperature x-ray structure of camp dependent protein kinase a in complex with high sr2+ concentration, adp and phosphorylated peptide psp20 |
|
105
|
347
|
4iz5A |
Structure of the complex between erk2 phosphomimetic mutant and pea-15 |
|
98
|
297
|
4jjrA |
A p21 crystal form of mammalian casein kinase 1 delta |
|
108
|
338
|
4ib1A |
Structure of camp dependent protein kinase a in complex with high k+ concentration, adp and phosphorylated peptide psp20 |
|
106
|
346
|
4ix6A |
Crystal structure of a stt7 homolog from micromonas algae soaked with atp |
|
86
|
309
|
4jg7A |
Structure of rsk2 ctd bound to 3-(3-(1h-pyrrolo[2,3-b]pyridine-3-carbonyl)phenyl)-2-cyanoacrylamide |
|
83
|
289
|
4i93A |
Structure of the bsk8 kinase domain (semet labeled) |
|
72
|
273
|
4id7A |
Ack1 kinase in complex with the inhibitor cis-3-[8-amino-1-(4-phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol |
|
75
|
287
|
4ithA |
Crystal structure of rip1 kinase in complex with necrostatin-1 analog |
|
71
|
266
|
4j8nA |
Aurora a kinase apo |
|
94
|
336
|
4ijpA |
Crystal structure of human prpf4b kinase domain in complex with 4-{5-[(2-chloro-pyridin-4-ylmethyl)-carbamoyl]-thiophen-2-yl}-benzo[b]thiophene-2-carboxylic acid amine |
|
91
|
297
|
4j97A |
Crystal structure of fgf receptor 2 (fgfr2) kinase domain harboring the pathogenic gain-of-function k659e mutation identified in endometrial cancer. |
|
86
|
324
|
4i23A |
Crystal structure of the wild-type egfr kinase domain in complex with dacomitinib (soaked) |
|
99
|
301
|
4ibmA |
Crystal structure of insulin receptor kinase domain in complex with an inhibitor irfin-1 |
|
95
|
354
|
4izyA |
Crystal structure of jnk1 in complex with jip1 peptide and 4-{4-[4-(4-methanesulfonyl-piperidin-1-yl)-indol-1-yl]-pyrimidin-2-ylamino}-cyclohexan |
|
73
|
273
|
4i41A |
Crystal structure of human ser/thr kinase pim1 in complex with mitoxantrone |
|
74
|
273
|
4iaaA |
Crystal structure of ser/thr kinase pim1 in complex with thioridazine |
|
104
|
346
|
4ix5A |
Crystal structure of a stt7 homolog from micromonas algae in complex with amp-pnp |
|
93
|
290
|
4jdkA |
Crystal structure of serine/threonine-protein kinase pak 4 f461v mutant in complex with paktide s peptide substrate |
|
95
|
354
|
4hysA |
Crystal structure of jnk1 in complex with jip1 peptide and 4-(4-indazol-1-yl-pyrimidin-2-ylamino)-cyclohexan |
|
108
|
336
|
4iafA |
Room temperature x-ray structure of camp dependent protein kinase a in complex with high mg2+ concentration, adp and phosphorylated peptide psp20 |
|
88
|
299
|
4j99A |
Crystal structure of fgf receptor 2 (fgfr2) kinase domain harboring the gain-of-function k659t mutation. |
|
189
|
659
|
4iwqA |
Crystal structure and mechanism of activation of tbk1 |
|
86
|
290
|
4i5cA |
The jak1 kinase domain in complex with inhibitor |
